Metformin Prolongs Survival in Type 2 Diabetes Lung Cancer Patients With EGFR-TKIs

Background: Metformin use reportedly reduces cancer risk and improves survival in lung cancer patients. This study aimed to investigate the effect of metformin use in patients with diabetes mellitus (DM) and lung cancer receiving epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI)...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Integr Cancer Ther
Main Authors: Hung, Ming-Szu, Chuang, Min-Chun, Chen, Yi-Chuan, Lee, Chuan-Pin, Yang, Tsung-Ming, Chen, Pau-Chung, Tsai, Ying-Huang, Yang, Yao-Hsu
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6696848/
https://ncbi.nlm.nih.gov/pubmed/31409137
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1534735419869491
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados